Commands a premium valuation multiple over its peers, likely pricing in superior execution.
Fragile underlying quality score of 24/100; weak margins or elevated debt leverage warrant caution.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Highly distressed profile flashing severe fundamental warning signs.
Wall Street sentiment is generally neutral alongside robust expected earnings growth. However, capital return yields remain modest, anchored by a strong, well-covered dividend yield.
PSKY struggles with subpar profitability and pressured margins. This is paired with a moderately leveraged but stable balance sheet.
The company is facing top-line contraction (-1.1% 3Y CAGR) paired with stable bottom-line earnings. However, profitability remains a major concern with severely compressed operating margins (-18.0%).
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $7.3B | — | -1.1% | +2.9% | +7.7% | |
| EBITDA | $978.0M | — | — | — | — | |
| Net Income | $547.0M | +0.0% | — | — | — | |
| EPS (Diluted) | $0.15 | +0.2% | — | — | — | |
| Free Cash Flow | $96.0M | +0.0% | — | -24.3% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 34.8% | 28.8% | 31.7% | 35.2% |
| Operating Margin | -18.0% | -4.7% | 3.1% | 10.7% |
| Net Margin | -0.8% | -15.3% | -5.3% | 2.1% |
| FCF Margin | 1.6% | 1.3% | 1.1% | 4.2% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.15 | $0.23 | +53.3% | ||
| Q1'26 | $-0.02 | $-0.12 | -500.0% | ||
| Q4'25 | $0.13 | $0.49 | +276.9% | ||
| Q3'25 | $0.41 | $0.46 | +12.2% | ||
| Q2'25 | $0.25 | $0.29 | +14.0% | ||
| Q1'25 | $0.18 | $-0.11 | -161.1% | ||
| Q4'24 | $0.24 | $0.49 | +100.6% | ||
| Q3'24 | $0.14 | $0.54 | +285.7% |
Total return is -19.4% (1Y), lagging the benchmark by -40.3%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -25.3% | -32.6% | — |
| 1Y | -19.4% | -40.3% | +1.6% |
| 3YCAGR | -12.3% | -31.9% | +3.9% |
| 5YCAGR | -22.4% | -33.6% | +5.4% |
| 10YCAGR | -11.0% | -25.1% | — |
The S&P 500 is at 30.6x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Paramount Skydance Corporation Class B Common Stock (PSKY) valuation, health, and returns.
Paramount Skydance Corporation Class B Common Stock is estimated to be fairly valued under our discounted cash flow framework. relative multiples indicate the stock is Expensive versus peers compared to industry peers. trading near fair value (DCF: $0.00)
Paramount Skydance Corporation Class B Common Stock has multiple valuation anchors: DCF Intrinsic Value: $0.00 | Peer Relative Fair Value: $6.46 | Wall Street Analyst Target: $10.00 (implying +3.7% upside). A convergence of these signals offers higher conviction.
Paramount Skydance Corporation Class B Common Stock displays weak financial health with a composite quality score of 24/100, supported by a Altman Z-Score of -0.0 (distress zone), Piotroski F-Score of 6/9, Return on Invested Capital (ROIC) of -14.7%.
Paramount Skydance Corporation Class B Common Stock pays a 0.5% dividend yield, covered by a 0% payout ratio with 0 years of growth, supplemented by a 0.0% buyback yield.
Paramount Skydance Corporation Class B Common Stock's current growth trajectory is Stable. The company achieved N/A 1Y revenue growth and +0.2% 1Y EPS growth, compared to its 3Y revenue CAGR of -1.1%.
Wall Street consensus is Sell based on 29 analysts, beating EPS expectations in 83% of recent quarters with a 1-quarter streak. The consensus price target represents a +3.7% change from current levels.
Investment risks for Paramount Skydance Corporation Class B Common Stock include: -55.4% 1-year max drawdown, elevated distress risk. Volatility risk is characterized by a beta of 0.75x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.